Leerink Partners Begins Coverage on Abbott Laboratories (NYSE:ABT)
Leerink Partners initiated coverage on shares of Abbott Laboratories (NYSE:ABT – Free Report) in a research note issued to investors on Monday, MarketBeat.com reports. The firm issued a market perform rating and a $143.00 price target on the healthcare product maker’s stock. Other equities research analysts have also issued reports about the stock. Jefferies Financial […]
Leerink Partners initiated coverage on shares of Abbott Laboratories (NYSE:ABT – Free Report) in a research note issued to investors on Monday, MarketBeat.com reports. The firm issued a market perform rating and a $143.00 price target on the healthcare product maker’s stock. Other equities research analysts have also issued reports about the stock. Jefferies Financial […]
